ValueAct Capital, LLC
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=5994839
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=5985596
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=5985496
COVINGTON, Ky.--(BUSINESS WIRE)-- Omnicare, Inc. (NYSE: OCR), one of the nation's leading providers of pharmaceutical care for the elderly, today announced that Jeffrey W. Ubben, founder, chief executive officer and chief investment officer of ValueAct Capital, has resigned as a member of its Board of Directors effective November 14, 2008. "I have resigned from the Omnicare Board of Directors in light of ValueAct Capital's reduced ownership stake in Omnicare and to focus my attention on other ValueAct Capital portfolio companies," said Mr. Ubben. "It has been an honor ...
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=5979558
-
Form 13F-HR ValueAct Holdings, L.P. For: Sep 30
-
Form 4 ACXIOM CORP For: Nov 10 Filed by: ValueAct Holdings GP, LLC
-
Form 4 ACXIOM CORP For: Nov 05 Filed by: ValueAct Holdings GP, LLC
-
Form 4 ACXIOM CORP For: Oct 31 Filed by: ValueAct Holdings GP, LLC
-
Acxiom Announces Resignation of Director Jeffrey Ubben
-
ValueAct Capital Strongly Disapproves of the Proposed Dilutive Stock Offering of Chimera Investment Corporation
-
Form 4 ValueAct Holdings GP, For: Oct 15
-
Form 4 ADVANCED MEDICAL OPTICS For: Oct 15 Filed by: ValueAct Holdings GP, LLC
-
Allscripts Announces Update on Allscripts-Misys Transaction
-
ValueAct Capital Boosts Stake in Alliance Data Systems (ADS) to 5.9%
-
ValueAct Partners Continues To Boosts Stake in Chimera Investment (CIM)
-
ValueAct Boosts Stake in Chimera Investment Corp. (CIM) to 9.9%
-
ValueAct Capital Boosts Stake in Chimera Investment (CIM) To 8.2%
-
ValueAct Capital Boosts Stake in Chimera Investment (CIM) To 6.7%
-
ValueAct Capital Lowers Stake in International Rectifier (IRF) to 3.8%
-
Buckingham Research Upgrades Omnicare (OCR) to Accumulate
-
Unusual 11 Mid-Day Movers 2/22: OPTV, ESST, NCI, FRPT Higher; BRLC, OFIX, UNFI, CBEY Lower
-
Omnicare (OCR) 10% Higher After ValueAct's Ubben Joins Board
-
ValueAct Capital Raises Stake in Sara Lee (SLE) to 6.1%
-
Following Eddie: Could Acxiom (ACXM) Be Worth A Look?
-
ValueAct Capital Discloses 5.2% Stake in International Rectifier (IRF)
-
ValueAct Capital Discloses 5% Stake in Sealy (ZZ)
-
ValueAct Capital Discloses 5% Stake in Sara Lee (SLE)
-
ValueAct Capital Boosts Stake in Equifax (EFX) to 7.2%
